✦ LIBER ✦

PL-009 Combination of telbivudine and adefovir dipivoxil therapy in chronic hepatitis B patients with poor response to adefovir dipivoxil monotherapy

✍ Scribed by E.-Q. Chen; T.-Y. Zhou; H. Tang

Book ID: 118617385
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 42 KB
Volume: 14
Category: Article
ISSN: 1201-9712
DOI: 10.1016/s1201-9712(10)60051-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of telbivudine plus

Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil

✍ Lu, Jia-Jie; Liu, Kai; Ma, Yuan-Ji; Wang, Juan; Chen, En-Qiang; Tang, Hong 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Comparative meta-analysis of adefovir di

Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B

✍ YongFa Chen; Ting Ju 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 1004 KB

Combination of Lamivudine and adefovir t

Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy

✍ L.-C. Wang; E.-Q. Chen; J. Cao; L. Liu; J.-R. Wang; B.-J. Lei; H. Tang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Resistance profile of adefovir dipivoxil

Resistance profile of adefovir dipivoxil (ADV) in immunocompetent and immunocompromised chronic hepatitis B patients after 48 weeks of adefovir dipivoxil therapy

✍ C.E. Westland; H. Yang; W.E. Delaney IV; V. Thibault; Y. Benhamou; C.S. Gibbs; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Increased risk of adefovir resistance in

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy

✍ Yoon-Seon Lee; Dong Jin Suh; Young-Suk Lim; Suk Won Jung; Kang Mo Kim; Han Chu L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

Although adefovir dipivoxil (ADV) has a unique profile of delayed and infrequent resistance in treatment-naïve chronic hepatitis B patients, the association of ADV resistance with previous lamivudine (LAM) resistance is not well understood. We compared the emergence of the ADV-resistant mutations rt

[524] PREDICTORS OF RESPONSE IN PATIENTS

[524] PREDICTORS OF RESPONSE IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B USING ADEFOVIR DIPIVOXIL THERAPY

✍ J. Li; H. Zhao; C.-W. Si; Y.-X. Zhang; X.-Y. Chen; L. Wang; X.-P. Tang 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 244 KB